Suppr超能文献

严重酒精性肝炎肝移植的选择性应用。

Selective use of liver transplantation for severe alcohol-associated hepatitis.

作者信息

Ayyala-Somayajula Divya, Han Hyosun, Terrault Norah A

机构信息

Department of Medicine, USC Keck School of Medicine, Los Angeles, CA, USA.

Division of Gastrointestinal and Liver Diseases, USC Keck School of Medicine, Los Angeles, CA, USA.

出版信息

Expert Rev Gastroenterol Hepatol. 2020 Mar;14(3):175-184. doi: 10.1080/17474124.2020.1733414. Epub 2020 Mar 3.

Abstract

: Severe alcohol-associated hepatitis (sAH) portends high morbidity and mortality and there are no effective therapies for those ineligible or unresponsive to corticosteroids. Early liver transplantation (LT) defined as transplantation without a mandated period of sobriety, for sAH, is being increasingly considered as a rescue therapy.: PubMed and manual searches were combined and last performed on 28 October 2019. Key search terms were 'alcoholic hepatitis', 'abstinence', 'alcohol relapse', and 'liver transplantation'. Terms were combined within each database. General reviews and references from published trials were also used.: Early LT is indicated in highly selected patients with sAH. While long-term data are sparse, 1 and 3-year survival post-transplantation are excellent and comparable to other liver diseases. Alcohol relapse is uncommon but approaches 10-25% at 3 years and if use is heavy and/or sustained leads to reduced survival. Thus, for continued application of transplantation for this indication, there is a need to further refine selection criteria and to optimize management of alcohol use disorder (AUD) in the transplant setting. Integral to advancing these objectives is the elimination of societal stigmatization and an acknowledgment that AUD is a medical condition that requires long-term management.

摘要

重度酒精性肝炎(sAH)预示着高发病率和高死亡率,对于那些不适合使用皮质类固醇或对其无反应的患者,目前尚无有效的治疗方法。早期肝移植(LT),即无强制戒酒期的肝移植,越来越多地被视为sAH的一种挽救疗法。通过结合PubMed检索和手工检索,最后一次检索时间为2019年10月28日。关键检索词为“酒精性肝炎”“戒酒”“酒精复饮”和“肝移植”。各检索词在每个数据库中进行组合。还使用了已发表试验的综述和参考文献。早期肝移植适用于经过严格筛选的sAH患者。虽然长期数据较少,但移植后1年和3年生存率良好,与其他肝病相当。酒精复饮并不常见,但3年时发生率接近10%-25%,如果饮酒量大和/或持续饮酒会导致生存率降低。因此,为了继续将移植用于该适应证,有必要进一步完善选择标准,并在移植环境中优化酒精使用障碍(AUD)的管理。实现这些目标不可或缺的是消除社会污名化,并承认AUD是一种需要长期管理的疾病。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验